stem cell therapy

Developed for: acute respiratory distress syndrome · decubitus ulcer · primary ovarian failure
Investigated by: Fudan University · Guangdong Provincial People's Hospital · Mongolian National University of Medical Sciences · Ningbo No. 1 Hospital · Peking Union Medical College Hospital · Renmin Hospital of Wuhan University
+7 more
· Second Affiliated Hospital, School of Medicine, Zhejiang University · Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University · The First Affiliated Hospital of Zhengzhou University · The Second Affiliated Hospital of Harbin Medical University · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · University Hospital, Basel, Switzerland · West China Hospital

200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 12 trials
Phase 1	NCT06132542	Jan → Oct 2024	primary ovarian failure	Mongolian National University of Medical Sciences	Unknown	No outcome recorded
Phase 1	NCT00535548	Jan → Dec 2007	decubitus ulcer	University Hospital, Basel, Switzerland	Unknown	No outcome recorded
Phase 41 trial
Phase 4	NCT05658692	Oct 2022 → Oct 2023	acute respiratory distress syndrome	Second Affiliated Hospital, School of Medicine, Zhejiang University	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	Stem cell therapy	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00535548 ↗ 2 NCT06132542 ↗ NCT05658692 ↗
Action	Restore	“We are planning to investigate the effectiveness of adipose stem cell on ovarian tissue regeneration for patients with premature ovarian failure.” NCT06132542 ↗
Modality	Cell therapy	“cell-based therapy” PMID 24476740 ↗ Jan 2014
Route	Other	“injected into the wound” PMID 24476740 ↗ Jan 2014